Transcript Slide 1
Colorectal Cancer Sunil T. Joseph, M.D. Epidemiology Third leading cause of cancer-related death in U.S. (lung) 112,340 estimated new cases in 2007; 52,000 deaths1 More than 90% cases in persons at least 50 years old2 5-6% lifetime risk for Americans1 , 1 in 18 $6.5 billion treatment costs in 20023 Epidemiology Annual incidence in U.S.: - M: 62 per 100,000 - F: 47 per 100,000 Increasing right sided colon cancers US has lowest mortality rate despite highest incidence CRC Death Rate Epidemiology Family History (10-30%) HNPCC (5%) Sporadic (65-85%) FAP (1%) Rare syndromes (<0.1%) Adenomas - Precursor lesions Polyps Tubular Adenomas -2/3 of polyps; 25% prevalence in> 50 Hyperplastic Polyps Villous Adenomas Serated Adenomas Projected Annual Hospital Admissions for Colon Cancer in the US: 1990-2050 Number of admissions (thousands) 500 400 300 200 Projected admissions, 50 yrs and over 100 0 1990 2000 2010 2020 2030 2040 2050 Year Seifeldin and Hantsch, Clin Ther 1999; 21: 1370 Average Annual Age-Specific US Incidence and Mortality Rates of CRC, 1992-1996 Number / 100,000 population 600 Incidence in men 500 400 300 Incidence in women Mortality in men Mortality in women 200 100 0 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Age group (years) Natl Cancer Inst, SEER Cancer Statistics Review 1973-1996 Signs and Symptoms • Blood in the stool-40% • Change in bowel habits-43% • Bowel obstruction • Abdominal/ Pelvic Pain-44% Signs and Symptoms • Weight Loss-6% • Loss of appetite • Fatigue-20% • Anemia w/out GI symptoms-11% Stages of Colon Cancer Stage I II III IV Mortality 90% 80% 50% 10% Reasons to Screen for CRC 1) 2) 3) 4) 5) 6) Long non-mailgnant pre-stage Long phase before symptoms emerge Early or pre-cancer stage detectable Curative tx available in pre-cancer stage Sensitive screening tests available Low screening risks Cost of Colorectal Cancer Screening vs Other Medical Practices Incremental cost / life year saved (US$) Colonoscopy every 10 years: 6,600 Breast cancer screening: 22,000 Heart transplantation: 160,000 Cervical cancer screening: 250,000 Colon cancer screening from age 55 years is cost-effective, but depends on compliance2 1Provenzale 2Lieberman et al, Am J Gastroenterol 1999; 94: 268 et al, Gastroenterology 1995; 109: 1781 Adherence Rates – Cancer Screening Breast Cancer Cervical Cancer Prostate Cancer Colorectal Cancer U.S. Adherence Rates 69% * 86% * 75%** 45% * 63%** * Seeff Cancer 2002;95:2211-22 **Sirovich JAMA 2003;289:1414-20 Factors Associated With CRC Risk factors Strong (RR > 4.0) Advanced age Country of birth FAP / HNPCC Long-standing ulcerative colitis Moderate (RR 2.1 - 4.0) High red meat diet Previous adenoma or cancer Pelvic irradiation Protective factors Moderate (RR < 0.6) High physical activity Aspirin / NSAIDs use Modest (RR 0.9 - 0.6) High vegetable / fruit diet High fiber diet High folate / methionine intake High calcium intake Postmenopausal hormone therapy Modest (RR 1.1 - 2.0) High fat diet Smoking and alcohol consumption Obesity Cholecystectomy Sandler, Gastroenterol Clin N Am 1996; 27: 717 Familial Adenomatous Polyposis -Autosomal dominant inheritance -100’s to 1000’s of polyps -Associated with gastric cancer -Polyps develop at age 20 -100% chance of developing colon cancer Lynch Syndrome (HNPCC) -Autosomal Dominant Inheritance -Proximal colon cancer -70% lifetime risk of developing cancer -Amsterdam criteria -Association with stomach, kidney, pelvic, and small bowel cancer Family History of CRC -Single 1st degree relative increases risk 1.7 X -Multiple relatives increases risk -Age less than 60 -Family history of tubular adenomas Guidelines • Annual Fecal Occult Blood Testing (FOBT) • Flexible Sigmoidoscopy Every 5 years • Annual FOBT and Flex Sig Every 5years • Colonoscopy Every10 years • Barium Enema Every 5-10 years Fecal Occult Blood Testing Proper Performance of slide Guaiac Test for Fecal Occult Blood For 3 days before and during testing, patients should avoid: • red meats • peroxidase-containing vegetables/fruits(broccoli, turnip, horseradish, cantelope, cauliflower, melon) • The following medicines: Vitamin C, Aspirin, NSAIDS Two samples of each of 3 spontaneously passed stool tested Slides should be developed within 4-6 days Slides should not be rehydrated before developing Limitations to FOBT False-positive results Exogenous peroxidase activity Red meat uncooked fruits and vegetables any source of GI blood loss(gingival, epistaxis, hemorrhoids, etc) medications ASA, NSAIDS False-Negative Results Storage of slides Ascorbic acid(Vitamin C) Improper sampling/ developing Lesion not detected at the time of stool collection Degradation of hemoglobin by colonic bacteria Barium Enema Barium Enema Positive Points Negative Points 1) Less Invasive 1) No sedation 2) No ride required 2) Full prep Low risk 3) Only diagnostic 4) Poor sensitivity 5) Radiation 3) exposure Endoscopy Flex Sig/Colonoscopy Polypectomy Endoscopy Flex Sig Colonoscopy -Enemas -Full Prep -No sedation/No ride -Sedation -1/3 of colon -Entire colon -Less risk -Dx and Therapeutic -Increased risk Cumulative Incidence of Colorectal Cancer in National Polyp Study Cohort Cumulative incidence of colorectal cancer (%) 5 No. expected from Mayo Clinic data 4 No. expected from St. Mark’s data 3 2 No. expected from SEER data 1 No. observed 0 0 1 2 3 4 5 6 7 8 Years of follow-up Winawer et al, New Engl J Med 1993; 329: 1977 Colonoscopy in Asx Pt’s • 3121 asx pt’s underwent full colonoscopy • TA in 37.5%, TA >1cm or villous in 7.9%, and invasive cancer in 1.0% • 52 % with proximal AN had no distal lesion • 0.3% complication rate, no perforations Lieberman et al, NEJM 2000; 343: 162-168. Withdrawl Times 12 private practice gastroenterologists performed 2053 screening colonoscopies in 15 months 23.5% of patients with adenomatous polyps Direct relation of colonoscope withdrawl time with adenoma detection; >6 minutes Greenlaw et al, NEJM 2006; 355: 2533-41. Flex Sig and Women • 1483 Asx women recruited from 4 sites • 4.9% had AN and 15.5% had small TA • Only 34.7% of AN detected on flex sig • 94% of prox AN with no distal findings • Colonoscopy may be recommended test for women Schoenfeld et al, NEJM 2005; 352: 2061-8. African-Americans and CRC Younger mean age at diagnosis (60-66y) Higher incidence rates Higher mortality rates More proximal distribution of cancers and adenomas ACG now recommends that screening begin at age 45 in African-Americans CT Colonography CT Colonography 1) Preparation: Go-Lytely vs. Fleets 2) Rectal tube: CO2 vs. Room air 3) Prone and Supine-Glucagon 4) Breath hold: 3-4X30 second/1X20 second 5) 2D/3D reconfiguration Advantages 1) Non-invasive 2) No sedation 3) Short exam time-20 minutes 4) Patient preference 5) Extra-colonic findings 6) Localization and both sides of folds Disadvantages 1) Prepped colon 2) Purely diagnostic 3) Radiation exposure 4) Significant learning curve 5) False positive: bowel distension/stool 6) Flat lesions What Can I Do to Prevent Colon Cancer? Prevention 1) Diet high in fruits and vegetables 2) Minimize red meat intake 3) Increased fiber intake 4) Folic acid/Vitamin D/Calcium 5) Increased physical activity Prevention 6) Aspirin/NSAID’s 7) Statins 8) Hormone replacement therapy Websites American Cancer Society Colon Cancer Alliance www.cancer.org www.ccalliance.org American Gastroenterolgy www.gastro.org Association